Literature DB >> 15899082

Evaluation of the serodia Treponema pallidum particle agglutination, the Murex Syphilis ICE and the Enzywell TP tests for serodiagnosis of syphilis.

G Aktas1, H Young, A Moyes, S Badur.   

Abstract

We evaluated the Treponema pallidum haemagglutination assay (TPHA), a treponemal test, with three other treponemal tests, the Serodia T. pallidum particle agglutination assay, the Murex Syphilis ICE IgG + IgM enzyme immunoassay (EIA) and the Enzywell TP IgG + M EIA (a new rapid EIA) for use in conjunction with the rapid plasma reagin test (RPR), a non-treponemal test, for serodiagnosis of syphilis. In all, 124 serum samples were found reactive with RPR and/or TPHA after testing by the routine laboratory protocol. Twenty-three (18.5%) of them were positive only by RPR test and were evaluated as biologically false-positive, 16 were positive only by the TPHA and 84 by both the RPR and TPHA tests; one sample was non-specific (heterophile reaction) in the TPHA. Agreements of the TPHA with the Serodia TPPA, the Murex Syphilis ICE and the Enzywell TP tests were 96.7%, 100% and 99.1%, respectively. We conclude that each one of the tests, the Serodia TPPA, the Murex Syphilis ICE and the Enzywell TP, is an appropriate substitute for screening for serodiagnosis of syphilis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15899082     DOI: 10.1258/0956462053654195

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  10 in total

1.  Characterization of Treponema pallidum particle agglutination assay-negative sera following screening by treponemal total antibody enzyme immunoassays.

Authors:  P A C Maple; D Ratcliffe; E Smit
Journal:  Clin Vaccine Immunol       Date:  2010-09-15

2.  Performance of CAPTIA SelectSyph-G enzyme-linked immunosorbent assay in syphilis testing of a high-risk population: analysis of discordant results.

Authors:  Vladana Woznicová; Zuzana Valisová
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948

3.  Consistency Between Treponema pallidum Particle Agglutination Assay and Architect Chemiluminescent Microparticle Immunoassay and Characterization of Inconsistent Samples.

Authors:  Li Zhiyan; Wang Meiling; Liu Ping; Dong Jinhua; Yan Zhenlin; Feng Zhenru
Journal:  J Clin Lab Anal       Date:  2014-05-19       Impact factor: 2.352

4.  Evaluation of the Determine Syphilis TP assay for the detection of antibodies against Treponema pallidum for the serodiagnosis of syphilis.

Authors:  Y-H Zhuang; Y Tian; Y Chen; J Tang; J-Q Wang; P Li; Q Li; Y-Q Jiang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-25       Impact factor: 3.267

5.  Comparative evaluation of 15 serological assays for the detection of syphilis infection.

Authors:  M J Cole; K R Perry; J V Parry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10       Impact factor: 3.267

6.  Evaluation of the recombinant protein TpF1 of Treponema pallidum for serodiagnosis of syphilis.

Authors:  Chuanhao Jiang; Feijun Zhao; Jinhong Xiao; Tiebing Zeng; Jian Yu; Xiaohua Ma; Haiying Wu; Yimou Wu
Journal:  Clin Vaccine Immunol       Date:  2013-08-14

7.  Evaluation of a particle gel immunoassay as a screening test for syphilis.

Authors:  S Borelli; A Monn; J Meyer; U Berger; H P Honegger; St Lautenschlager
Journal:  Infection       Date:  2009-01-23       Impact factor: 3.553

8.  Comparative study of Treponemal and non-Treponemal test for screening of blood donated at a blood center.

Authors:  Narinder Kaur Naidu; Z S Bharucha; Vandana Sonawane; Imran Ahmed
Journal:  Asian J Transfus Sci       Date:  2012-01

9.  The Traditional or Reverse Algorithm for Diagnosis of Syphilis: Pros and Cons.

Authors:  Daniel A Ortiz; Mayur R Shukla; Michael J Loeffelholz
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

10.  The trade-off between accuracy and accessibility of syphilis screening assays.

Authors:  Pieter W Smit; David Mabey; John Changalucha; Julius Mngara; Benjamin Clark; Aura Andreasen; Jim Todd; Mark Urassa; Basia Zaba; Rosanna W Peeling
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.